Abstract, Snapshot, Market Analysis & Market Definition: Dalbavancin Market
Dalbavancin is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin, the most widely used and one of the few treatments available to patients infected with methicillin-resistant Staphylococcus aureus (MRSA). Dabavan star is a new antibiotic developed by Durata, named Dalvance, which was approved by FDA to be marketed in the United States on May 23, 2014. It is used to treat complex acute bacterial skin and skin structure infections in adults. The drug is a second-generation glycopeptide antibiotic given intravenously. In 2019, the market size of Dalbavancin is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dalbavancin. This report studies the global market size of Dalbavancin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Dalbavancin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
Market Segmentation, Outlook & Regional Insights: Dalbavancin Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Intravenous Therapy
Oral Type
Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:
Skin Infection
Soft Tissue Infection
Others
Key Players, Recent Developments & Sector Viewpoints: Dalbavancin Market
Roche
Pfizer
Abbvie
Johnson
Sanofi
Merck
Novartis
Gilead
GSK
Amgen
Hayao
Key Insights Covered: Exhaustive Dalbavancin Market
1. Market size (sales, revenue and growth rate) of Dalbavancin industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Dalbavancin industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Dalbavancin industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Dalbavancin industry.
Research Methodology: Dalbavancin Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.